000 01472 a2200409 4500
005 20250513111756.0
264 0 _c19970227
008 199702s 0 0 eng d
022 _a0277-3732
024 7 _a10.1097/00000421-199702000-00015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIngle, J N
245 0 0 _aEvaluation of intravenous 6-thioguanine as first-line chemotherapy in women with metastatic breast cancer.
_h[electronic resource]
260 _bAmerican journal of clinical oncology
_cFeb 1997
300 _a69-72 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntimetabolites, Antineoplastic
_xadministration & dosage
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aRemission Induction
650 0 4 _aSurvival Analysis
650 0 4 _aThioguanine
_xadministration & dosage
700 1 _aTwito, D I
700 1 _aSuman, V J
700 1 _aKrook, J E
700 1 _aMaillard, J A
700 1 _aWindschitl, H E
700 1 _aMarschke, R F
773 0 _tAmerican journal of clinical oncology
_gvol. 20
_gno. 1
_gp. 69-72
856 4 0 _uhttps://doi.org/10.1097/00000421-199702000-00015
_zAvailable from publisher's website
999 _c9010531
_d9010531